Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapy.
1/5 보강
Genome-wide association studies (GWAS) have identified germline genetic variants for follicular lymphoma (FL) susceptibility.
- 표본수 (n) 1054
APA
Ghesquières H, Drouet Y, et al. (2026). Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapy.. Blood cancer journal, 16(1), 22. https://doi.org/10.1038/s41408-025-01435-1
MLA
Ghesquières H, et al.. "Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapy.." Blood cancer journal, vol. 16, no. 1, 2026, pp. 22.
PMID
41513626 ↗
Abstract 한글 요약
Genome-wide association studies (GWAS) have identified germline genetic variants for follicular lymphoma (FL) susceptibility. We conducted a GWAS of prognosis in FL patients to identify genetic predictors of event-free survival (EFS) as well as failure within the first 24 months after treatment initiation (EFS24) using patients treated with rituximab-based immunochemotherapy from three clinical trials and one prospective observational study (N = 1054). Statistical approaches consisted of a pooled GWAS of the four cohorts and a leave-one-cohort-out (LOCO) strategy to identify robust findings that replicated across the four cohorts. The top SNPs for EFS and EFS24 were marked by rs72625024 at 3q27.3 near FETUB and HRG (P = 9.37 × 10) and rs114695031 at 14q32.13 near TCL6 (P = 1.93 × 10), respectively. These two loci, which were discovered and validated in all 4 LOCO rounds, map near long-non-coding RNAs with putative tumor suppressor functions. Our results pinpoint potential novel biology and the contribution of host genetics to prognosis in FL.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.